Exchange: NYSE·Updated 12:59 PM EDT
News
all
press releases
TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises
Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.
Zacks
More News
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
ALC's Q2 earnings and sales beat estimates as equipment and ocular health gains lift results, while the company raises its 2026 EPS outlook.
Zacks
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and cost risks support a measured view.
Zacks
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down
Insulet's Q2 results beat estimates on strong Omnipod demand and wider margins, but its 2026 revenue outlook takes a hit.
Zacks
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma PR Newswire BURLINGTON, N.C., Aug. 10, 2026 Labcorp's FDAapproved PGDx elio tissue complete CDx helps...
PR Newswire
PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised
Prestige Consumer's Q1 earnings and revenues outpace estimates as acquisitions boost its fiscal 2027 outlook despite margin pressure.
Zacks
RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y
Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.
Zacks
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation
LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median.
Zacks
CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs
CVS beats Q2 earnings and revenue estimates as stronger segment performance lifts results and prompts raised 2026 guidance, sending shares higher.
Zacks

Advertisement|Remove ads.